Literature DB >> 5855251

Effect of atromid and its components on uric acid excretion and on gout.

G Trevaks, R R Lovell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5855251      PMCID： PMC1010409          DOI： 10.1136/ard.24.6.572

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  10 in total

1.  Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man.

Authors:  T F YU; A B GUTMAN
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

2.  THE TREATMENT OF HYPERCHOLESTEROLAEMIC XANTHOMATOSIS WITH ATROMID.

Authors:  E M JEPSON; D C JAMES
Journal:  J Atheroscler Res       Date:  1963 Sep-Dec

3.  SERUM LIPID AND LIPOPROTEIN CHANGES AFTER TREATMENT WITH ATROMID IN PATIENTS WITH ATHEROSCLEROSIS, ESSENTIAL HYPERLIPAEMIA AND FAMILIAL HYPERCHOLESTEROLAEMIA.

Authors:  A FASOLI; A CESANA
Journal:  J Atheroscler Res       Date:  1963 Sep-Dec

4.  REDUCTION OF CHOLESTEROL AND LIPIDS IN MAN BY ETHYL P-CHLOROPHENOXYISOBUTYRATE.

Authors:  L HELLMAN; B ZUMOFF; G KESSLER; E KARA; I L RUBIN; R S ROSENFELD
Journal:  Ann Intern Med       Date:  1963-10       Impact factor: 25.391

5.  The enzymatic spectrophotometric method for determination of uric acid.

Authors:  L LIDDLE; J E SEEGMILLER; L LASTER
Journal:  J Lab Clin Med       Date:  1959-12

6.  Evaluation of uricosuric agents in chronic gout.

Authors:  M A OGRYZLO; J HARRISON
Journal:  Ann Rheum Dis       Date:  1957-12       Impact factor: 19.103

7.  Reduction of serum-lipid and uric-acid levels by an orally active androsterone.

Authors:  M F OLIVER
Journal:  Lancet       Date:  1962-06-23       Impact factor: 79.321

8.  Endogenous creatinine in serum and urine.

Authors:  R S HARE
Journal:  Proc Soc Exp Biol Med       Date:  1950-05

9.  EFFECTS OF ETHYL CHLOROPHENOXYISOBUTYRATE, ALONE OR WITH ANDROSTERONE (ATROMID) ON SERUM LIPIDS, LIPOPROTEINS AND RELATED METABOLIC PARAMETERS IN NORMAL AND HYPERLIPIDEMIC SUBJECTS.

Authors:  R P HOWARD; P ALAUPOVIC; O J BRUSCO; R H FURMAN
Journal:  J Atheroscler Res       Date:  1963 Sep-Dec

10.  MULTICENTRE TRIAL IN THE UNITED KINGDOM AND IRELAND OF A MIXTURE OF ETHYL CHLOROPHENOXYISOBUTYRATE AND ANDROSTERONE (ATROMID). A PRELIMINARY REPORT.

Authors:  K G GREEN; W H INMAN; J M THORP
Journal:  J Atheroscler Res       Date:  1963 Sep-Dec
  10 in total
  6 in total

1.  Proceedings: Gout, hypertriglyceridaemia, and alcohol consumption.

Authors:  T J Gibson; R Grahame
Journal:  Ann Rheum Dis       Date:  1974-01       Impact factor: 19.103

2.  Xanthomatosis, hyperlipoproteinaemia (type II, Fredrickson), gout, cardiac infarction.

Authors:  G O Storey
Journal:  Proc R Soc Med       Date:  1971-01

3.  Hyperlipoproteinaemia in gout.

Authors:  R Bluestone; B Lewis; I Mervart
Journal:  Ann Rheum Dis       Date:  1971-03       Impact factor: 19.103

Review 4.  Pharmacology of uricosuric drugs.

Authors:  I Kippen; M W Whitehouse; J R Klinenberg
Journal:  Ann Rheum Dis       Date:  1974-07       Impact factor: 19.103

5.  Hypouricaemia and increased renal urate clearance associated with hyperparathyroidism.

Authors:  T Gibson; H P Sims; S A Jimenez
Journal:  Ann Rheum Dis       Date:  1976-08       Impact factor: 19.103

6.  Mechanism and treatment of hypertriglyceridaemia in gout.

Authors:  T Gibson; K Kilbourn; I Horner; H A Simmonds
Journal:  Ann Rheum Dis       Date:  1979-02       Impact factor: 19.103
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.